Skip to content

Diagnosis of "Changsangjun Pulse Method for Pulse Resting" and Evaluation of Clinical Effect of Acupuncture and Demonstration Study

Diagnosis of "Changsangjun Pulse Method for Pulse Resting" and Evaluation of Clinical Effect of Acupuncture and Demonstration Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058393
Enrollment
Unknown
Registered
2022-04-08
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Interventions

1-1:diminished Qi acupuncture
1-2:pathway of mind acupuncture
1-3:diminished Qi and pathway of mind acupuncture
1-4:control acupuncture
1-5:sham acupuncture
2-1:pathway of mind acupuncture
2-2:control acupuncture
2-3:sham acupuncture
3-1:Pulse unrest acupuncture
3-2:pathway of mind acupuncture
3-3:Pulse unrest and pathway of mind acupuncture
3-4:control acupuncture
3-5:sham acupuncture

Sponsors

Ningxia Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.18 years = age =65 years; 2. Meet the diagnostic criteria of migraine without aura and migraine with aura; 3. In recent 3 months, the number of attacks per month is greater than or equal to 2; 4. Have a history of migraine for more than half a year; 5. Informed consent form signed by the patient himself or by his immediate family member.

Exclusion criteria

Exclusion criteria: 1. Headache caused by organic diseases, such as subarachnoid hemorrhage, cerebral hemorrhage, cerebral embolism, cerebral thrombosis, vascular malformation, arteritis, hypertension or arteriosclerosis; 2. There are nervous system diseases, immune deficiency, bleeding diseases or other diseases; 3. Take drugs to prevent migraine in recent 4 weeks; 4. Pregnant women and lactating women; 5. Those who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
VAS score;

Secondary

MeasureTime frame
Pulse-Breath Ratio;Headache (migraine) symptom score;SF-36;average headache severity;migraine-specific quality-of-life questionnaire (MSQ);Efficacy Evaluation;

Countries

China

Contacts

Public ContactHuang Yinlan

Ningxia Medical University

lzdbe@163.com+86 18209506917

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026